Shoulder Innovations (SI) Stock Price

Shoulder Innovations Price

NYSE·CLOSED
18.25
​
Market closed

Revenue has compounded at 2.7% per year over the past 9 years to 47.25 M USD. Earnings per share have grown at 36.6% per year over the last 6 years. Shoulder Innovations's net margin stands at -85.4%, down from 43.2% several years earlier. Analysts set a median price target of 23.50 USD, implying 28.8% above the current price. Of 12 analysts, 11 rate the stock a buy — an overall Buy consensus.

Shoulder Innovations stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shoulder Innovations business model & stock analysis

Shoulder Innovations Inc generates revenue through its advanced implant systems for shoulder arthroplasty, specifically the aTSA and rTSA systems, which address patient and surgeon needs with customizable configurations for anatomic or reverse procedures. The company's ecosystem includes enabling technologies, instrument systems, specialized support, and surgeon-to-surgeon collaboration, enhancing preoperative planning, implant design, and procedural efficiency across the care chain. Its InSet Glenoid technology forms the foundational element of these systems, supporting comprehensive surgical solutions for healthcare providers. The firm targets hospitals and surgical centers as primary buyers, leveraging its commercial-stage medical technology focus to serve the shoulder surgical care market. The company's product portfolio centers on aTSA and rTSA systems, designed to improve core components of shoulder surgical care, with InSet Glenoid as the cornerstone of its implant solutions. These systems are sold to healthcare institutions seeking advanced surgical tools that streamline procedures and improve patient outcomes. Shoulder Innovations Inc capitalizes on its ecosystem approach, bundling implant systems with enabling technologies and support services to create a cohesive offering for medical professionals. The firm’s commercial-stage position allows it to directly engage with hospitals and surgical centers as key customers in the healthcare equipment and supplies sector. Shoulder Innovations Inc's revenue model relies on selling its advanced implant systems, including aTSA and rTSA, alongside InSet Glenoid technology, to hospitals and surgical centers. The company emphasizes procedural efficiency and preoperative planning through its ecosystem, which includes instrument systems and surgeon collaboration tools. By focusing on shoulder arthroplasty, the firm targets a specialized segment within the healthcare market, offering tailored solutions that address both patient requirements and surgical workflow optimization. The company’s products are designed to integrate seamlessly into existing surgical practices, enhancing care delivery across the shoulder surgical care chain.

Frequently asked questions about Shoulder Innovations

Analysts currently set an average price target of 23.50 USD for the Shoulder Innovations stock (median: 23.50 USD), implying +28.8 % versus the latest price. The consensus is based on 12 analyst ratings.

12 analysts currently rate the Shoulder Innovations stock: 11 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Shoulder Innovations to generate revenue of 68.43 M USD and earnings per share of -1.88 USD.

Converted at the current exchange rate, the Shoulder Innovations share trades at 16.27 EUR (18.25 USD).

The expected revenue of Shoulder Innovations is 68.43 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Shoulder Innovations is -38.70 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Shoulder Innovations is currently -9.72. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Shoulder Innovations stock.

The price-to-sales ratio (P/S) of Shoulder Innovations is currently 5.49. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Shoulder Innovations stock.

The Eulerpool Quality Score for Shoulder Innovations is 2/10.

The ISIN of Shoulder Innovations is US82537J1088. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Shoulder Innovations is SI. The ticker symbol is used to trade Shoulder Innovations shares on the stock exchange.

Fair ValueTerminal
18.07 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
656,208.33 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Jul 31, 2025
ISIN
US82537J1088
Cusip
82537J108
Market capitalization
375.95 M USDSmall Cap
52-Week Range
PEG
1.07
P/E ratio
P/Ee 2026
-9.72
P/Ee 2027
-11.63
P/Ee 2028
-12.78
P/S
P/Se
5.49
EV/EBIT
—
P/B Ratio
2.67
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-25.91 %
Last updated Oct 20, 2026, 12:42 PM